PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA

Detalles Bibliográficos
Autores principales: Segura, Cecilia Carmen Carpio, Namuduri, Manjusha, Liu, Dishan, Sophos, Nickolas A., Zhu, Min, Sabir, Ayesha, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Garcia-Sancho, Alejandro Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428946/
http://dx.doi.org/10.1097/01.HS9.0000976180.72680.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428946/
http://dx.doi.org/10.1097/01.HS9.0000976180.72680.25

Ejemplares similares